<DOC>
	<DOC>NCT00374036</DOC>
	<brief_summary>The purpose of this study is to compare the effectiveness of 2 different sequences of polychemotherapy among carrying patients of a adenocarcinoma of the stomach or cardia locally advanced or metastatic.</brief_summary>
	<brief_title>Metastatic Gastric Cancer FFCD 03-07</brief_title>
	<detailed_description>To compare the effectiveness of two different sequences of polychemotherapy among carrying patients of a adenocarcinoma of the stomach or cardia locally advanced or metastatic.</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>age = 18 years old patients carrying a adenocarcinoma of the stomach or cardia histologically proven locally advanced tumour which may not be treated surgically or metastatic tumour the patients having a stenosante tumour responsible for a disphagy had to have a tumoral ablation or a prosthesis or a probe of food, measurable lesions according to criteria RECIST (specify measurement by spiral scanner of largest diameter of with less the one lesion of size higher than 1 cm) or appraisable but nonmeasurable (lesions &lt; 1 cm, ascite, pleural effusion...) general state WHO &lt; 2 absence of insufficiency cardiac or coronary symptomatic absence of previous chemotherapy other that auxiliary stopped since more than 6 months filled questionnaires QLQ C30 and STO22 PNN = 1500/mm3, haemoglobin ≥ 10g/dl, plates= 100 000/mm3 creatinin ≤ 110 micromol/l bilirubin ≤ 35 micromol/l disphagy or intestinal obstruction incompatible with a treatment per os or by a probe of food pregnant or nursing woman previous of cardiac toxicity to the 5FU or to the anthracyclines radiotherapy less than 3 weeks before inclusion, whatever the site other evolutionary cancer threatening the shortterm life metastasis cerebral or méningée known (without obligation to seek it) impossibility of regular followup for psychological, social, family or geographical reasons</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>chemotherapy</keyword>
	<keyword>stomach cancer metastatic</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>Irinotecan</keyword>
</DOC>